English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1517844      線上人數 : 382
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29305


    題名: Donor-gifted allograft urolithiasis: Early percutaneous management
    作者: Lu, HF;Shekarriz, B;Stoller, ML
    貢獻者: 附設醫院泌尿部;Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA;China Med Coll Hosp, Dept Urol, Taichung, Taiwan
    日期: 2002
    上傳時間: 2010-09-24 14:31:35 (UTC+8)
    出版者: ELSEVIER SCIENCE INC
    摘要: A mixture of poly(ethylene-co-vinyl alcohol) (EVAL),dimethylsulfoxide(DMSO) and doxorubicin was precipitated from the 1-octanol to form membranes with particles bonded to each other. The drug release profile from the EVAL membrane was investigated for 96h. Results showed that the release behavior of doxorubicin was increasing with time and a two-step release behavior, a fast and a slow releasing pattern was revealed. It was also found that the number of cancer cells could be significantly decreased by released doxorubicin from the EVAL membrane. It is concluded that the EVAL copolymer could be an ideal encapsulating material for drugs to treat chronic diseases. (C) 2002 Elsevier Science B.V. All rights reserved.
    關聯: UROLOGY 59(1):25-27
    顯示於類別:[台中附設醫院] 期刊論文

    文件中的檔案:

    沒有與此文件相關的檔案.



    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋